Advertisement
The HALO® Platform is a rapid, high-throughput, multifunctional hemotoxicity testing system that can be used at all stages of drug development from screening to clinical trials. HALO® is a proliferation assay with a luminescence readout performed in a 96-well plate. The platform allows up to 11 different stem, progenitor, and precursor cell populations, from different hematopoietic tissues and several species, to be detected and quantitatively measured simultaneously. Parameters measured include: peripheral blood, bone marrow, and umbilical cord blood (human) cell types, and species including human, non-human primate (Rhesus and Cynmologus), dog, rat, and mouse.
Advertisement
Advertisement